SAMBATARO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.851
EU - Europa 734
AS - Asia 439
AF - Africa 153
SA - Sud America 3
OC - Oceania 1
Totale 3.181
Nazione #
US - Stati Uniti d'America 1.844
IT - Italia 403
SG - Singapore 295
IE - Irlanda 177
CI - Costa d'Avorio 128
CN - Cina 108
RU - Federazione Russa 27
DE - Germania 22
VN - Vietnam 22
FI - Finlandia 20
GB - Regno Unito 20
SN - Senegal 17
FR - Francia 16
NL - Olanda 12
UA - Ucraina 10
CZ - Repubblica Ceca 9
NG - Nigeria 8
CA - Canada 7
BE - Belgio 5
HK - Hong Kong 4
JP - Giappone 4
CH - Svizzera 3
AT - Austria 2
CL - Cile 2
GR - Grecia 2
LB - Libano 2
SE - Svezia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SI - Slovenia 1
TR - Turchia 1
Totale 3.181
Città #
Santa Clara 689
Singapore 224
Chicago 223
Chandler 218
Dublin 177
Abidjan 128
Boardman 119
Civitanova Marche 72
Ashburn 65
Catania 63
Cambridge 34
Lawrence 34
Andover 32
Palermo 25
Des Moines 22
Dong Ket 20
Los Angeles 19
Dakar 17
Lappeenranta 14
Nanjing 14
Jacksonville 13
Milan 13
Wilmington 12
Bremen 10
San Giovanni la Punta 10
Amsterdam 9
Ferentino 9
Munich 9
Abuja 8
Woodbridge 8
Brno 7
Falls Church 7
Helsinki 6
Messina 6
Saint Petersburg 6
Seattle 6
Washington 6
Toronto 5
Assago 4
Latina 4
Paris 4
Pennisi 4
Phoenix 4
Rome 4
Turin 4
Belpasso 3
Brussels 3
Buccheri 3
Capriva del Friuli 3
Corato 3
Hong Kong 3
Jiaxing 3
Nanchang 3
Norwalk 3
Ragusa 3
Reggio Emilia 3
San Francisco 3
Shanghai 3
Sulzano 3
Tokyo 3
Acate 2
Aci Sant'Antonio 2
Ann Arbor 2
Bresso 2
Cattolica 2
Cecina 2
Changsha 2
Den Haag 2
Fairfield 2
Hangzhou 2
Hanoi 2
Hebei 2
Houston 2
Jesi 2
Jinan 2
Leuven 2
London 2
Naples 2
North Bergen 2
Northfield 2
Paterno 2
Patti 2
Pavia 2
Pozzallo 2
Pozzo Di Gotto 2
Reggio Calabria 2
Riposto 2
San Gregorio di Catania 2
Santiago 2
Shenyang 2
Shenzhen 2
Siracusa 2
Taizhou 2
Viagrande 2
Aci Catena 1
Adelaide 1
Anyang 1
Augusta 1
Bari 1
Beijing 1
Totale 2.506
Nome #
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 113
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 79
INVOLVEMENT OF OXIDATIVE STRESS AND VITAMINS D,C AND A IN SYSTEMIC SCLEROSIS: IN RELATION TO CLINICAL DISEASE ACTIVITY PARAMETERS 73
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 68
Comorbidities of IPF: How do they impact on prognosis 63
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 63
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 62
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 62
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 62
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 61
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 60
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 59
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 59
Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features 57
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 57
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 56
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 54
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 54
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 52
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 49
Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification 49
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 49
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 48
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Reply 48
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 47
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 46
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 44
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 44
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 43
Calcineurin inhibitor-based immunosuppression and COVID-19: Results from a multidisciplinary cohort of patients in Northern Italy 41
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes 41
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 40
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 40
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 39
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 39
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 38
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 38
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 36
Eosinophilic Interstitial Pneumonia 36
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 35
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 34
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 34
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 33
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 33
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 32
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 30
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: currentissues and future perspectives 30
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 30
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 27
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 26
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 25
Developing PI3K Inhibitors for Respiratory Diseases 24
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 24
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 24
Present and future of biologic drugs in primary Sjögren’s syndrome 24
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the {COVAD} surveys 22
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 22
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 22
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 22
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 21
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 21
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 20
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 20
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 19
{COVAD} survey 2 long-term outcomes: unmet need and protocol 19
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 18
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 18
Impact of {COVID}-19 outbreak in an Italian cohort of patients with systemic sclerosis 18
High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis 18
Interstitial lung disease and anti-myeloperoxidase antibodies: Not a simple association 18
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 18
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 17
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 17
Autoimmunity in Interstitial Lung Disease 17
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 16
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 16
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 16
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 16
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 16
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 16
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 15
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 15
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 15
Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study 15
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study 15
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 15
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 15
A die-hard giant capillary 15
Systemic lupus erythematosus patients with and without neuropsychiatric manifestations: a neck and transcranial duplex sonography study 14
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation 14
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 14
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 14
Reply to J. Magalon et al 14
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 14
Impaired physical function in patients with idiopathic inflammatory myopathies: Results from the multicentre COVAD patient-reported e-survey 14
Update on Treatment of Antisynthetase Syndrome: A Brief Review 14
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 13
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 13
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 13
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 13
Totale 3.281
Categoria #
all - tutte 15.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 5 5 1 0 6 3 7
2020/2021170 7 27 11 5 50 6 21 3 18 2 4 16
2021/2022234 6 38 3 16 43 6 36 11 6 6 3 60
2022/2023688 37 55 6 63 68 93 21 110 150 16 41 28
2023/2024655 24 72 83 34 31 136 4 28 6 43 104 90
2024/20251.506 45 352 127 177 479 326 0 0 0 0 0 0
Totale 3.351